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Characterization of Cofactor-Induced Folding Mechanism of a Zinc Binding
Peptide Using Computationally Designed Mutants
Abstract
Metals are the most commonly encountered protein cofactors, and they play important structural and
functional roles in biology. In many cases, metal binding provides a major driving force for a polypeptide
chain to fold. While there are many studies on the structure, stability, and function of metal-binding
proteins, there are few studies focusing on understanding the kinetic mechanism of metal-induced
folding. Herein, the Zn(2+)-induced folding kinetics of a small zinc-binding protein are studied; the CH1(1)
peptide is derived from the first cysteine/histidine-rich region (CH1 domain) of the protein interaction
domains of the transcriptional coregulator CREB-binding protein. Computational design is used to
introduce tryptophan and histidine mutations that are structurally consistent with CH1(1); these mutants
are studied using stopped-flow tryptophan fluorescence experiments. The Zn(2+)-induced CH1(1) folding
kinetics are consistent with two parallel pathways, where the initial binding of Zn(2+) occurs at two sites.
However, the initially formed Zn(2+)-bound complexes can proceed either directly to the folded state
where zinc adopts a tetrahedral coordination or to an off-pathway misligated intermediate. While
elimination of those ligands responsible for misligation simplifies the folding kinetics, it also leads to a
decrease in the zinc binding constant. Therefore, these results suggest why these nonnative zinc ligands
in the CH1(1) motif are conserved in several distantly related organisms and why the requirement for
function can lead to kinetic frustration in folding. In addition, the loop closure rate of the CH1(1) peptide is
determined based on the proposed model and temperature-dependent kinetic measurements.
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Zinc Binding Peptide Using Computationally Designed Mutants
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Abstract
Metals are the most commonly encountered protein cofactors, and they play important structural and
functional roles in biology. In many cases, metal-binding provides a major driving force for a
polypeptide chain to fold. While there are many studies on the structure, stability, and function of
metal-binding proteins, there are few studies focusing on the understanding of the kinetic mechanism
of metal-induced folding. Herein, the Zn2+-induced folding kinetics of a small zinc-binding protein
are studied; the CH11 peptide is derived from the first cysteine/histidine-rich region (CH1 domain)
of protein interaction domains of the transcriptional coregulator CBP. Computational design is used
to introduce tryptophan and histidine mutations that are structurally consistent with CH11; these
mutants are studied using stopped-flow tryptophan fluorescence experiments. The Zn2+-induced
CH11 folding kinetics are consistent with two parallel pathways, where the initial binding of Zn2+
occurs at two sites. However, the initially formed Zn2+-bound complexes can proceed either directly
to the folded state where zinc adopts a tetrahedral coordination or to an off-pathway, misligated
intermediate. While elimination of those ligands responsible for misligation simplifies the folding
kinetics, it also leads to a decrease in the zinc binding constant. Therefore, these results suggest why
these non-native zinc ligands in the CH11 domain are conserved in several distantly related organisms
and that the requirement for function can lead to kinetic frustration in folding. In addition, the loop
closure rate of the CH11 peptide is determined based on the proposed model and temperature
dependent kinetic measurements.

Keywords
Protein folding; computational design; stopped-flow fluorescence; zinc-binding peptides; folding
intermediate

Introduction
The study of the folding mechanism of single domain proteins that lack cofactors has reached
an advanced stage wherein the sequence of events along the course of refolding after
denaturation begins to be understood.1–10 In several cases, it has been even possible to describe
in detail the energetics, position, and structure of the folding transition state ensembles and/or
intermediate states involved.2,3,7–9 In contrast, there are far fewer studies on cofactor-induced
folding kinetics, even though a large number of proteins require cofactors for proper folding
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and/or function.11,12 While the effect of cofactor-binding on the structure and stability may
differ for different proteins, many polypeptides can only attain a well-folded structure when
associated with their respective cofactors. For example, cytochrome c, an important electron
transfer protein, cannot fold without incorporation of its heme cofactor.12 Similarly, many
small metal-binding peptides, such as the zinc finger motif,13,14 also require their respective
cofactors to maintain the integrity of their native fold. For such systems, cofactor-binding thus
provides not only stabilization but also a major driving force directing the folding of an
otherwise unstructured protein to a well-defined structure. Nonetheless, the prerequisite of a
cofactor for folding may complicate the folding free-energy landscape and thus the kinetic
mechanism,15 because cofactor-binding often requires the formation of a precisely defined
cofactor-binding environment in the native state. In addition, a protein may also transiently
associate with a cofactor in a non-native fashion, leading to kinetic frustration in folding. For
example, cytochrome c exhibits rather complex folding kinetics arising from non-native iron
ligation during or prior to folding.16–20 Herein, the folding of designed variants of a small
Zn2+-binding protein are examined in an effort to probe the roles of native and non-native
interactions in the folding kinetics of metal-binding proteins.
Metal ions, such as Zn2+, Mg2+ and Ca2+, are among the most commonly encountered
cofactors. Metal-binding not only plays many important structural and functional roles in cells,
21 but it is also increasingly used in de novo protein designs to generate or stabilize a specific
fold.22–32 For example, when coordinated with a metal ion, polypeptides composed of several
heptad repeats are observed to undergo a transition from a disordered conformation to an αhelical coiled-coil structure.24,32 Despite the increase in the number of metal-binding peptides
(or domains) designed and discovered in recent years, studies on metal-induced folding kinetics
are scarce.25,33–35 Moreover, small miniproteins have led to advances in our understanding of
elementary events in protein folding and detailed comparisons between theory and experiment.
36–39 Similarly, it is useful to identify and develop small cofactor-containing miniproteins that
lend themselves to kinetic folding studies. To provide further insight into the understanding of
the mechanism of metal-mediated protein folding processes, herein we have carried out
detailed stopped-flow studies of the Zn2+-induced folding kinetics of computationallydesigned variants of a zinc-binding motif, the CH11 peptide.
The CH11 peptide (sequence: 1 EVRACSLPHC-11 RTMKNVLNHM-21 THCQAGK) is a
highly conserved motif found in the first cysteine/histidine-rich (Cys/His-rich) region (CH1
domain) of protein interaction domains of the transcriptional coregulator CBP (CREB binding
protein).40 NMR studies have revealed that the CH11 peptide binds a single Zn2+ ion through
coordination with the side chain of C5, C10, H19, and C23 residues, and that the folded
structure is composed of a 310-helix and a short α-helical stretch packing around the zinc
(Figure 1). The CH11 peptide has also been termed as CHANCE finger (or a Cys/His-rich
peptide exhibiting an unexpected conformational ensemble) as it constitutes a new protein fold.
40 Previous studies40, 41 have shown that this CHANCE fold is not only thermally stable (no
substantial secondary structural changes occur up to 85 °C as judged by CD), but is also tolerant
to both multiple-alanine (Ala) mutations and changes in the sequence spacing of the zincligating ligands. In addition, it is found that the two non-native ligands, especially His22, are
conserved in the CH11 sequence in several distantly related organisms,40 suggesting that they
may be functionally important, for example, by facilitating ligand binding via non-native
interactions. However, such interactions are expected to occur at the expense of introducing
frustration in the folding kinetics. Thus, the advantages of studying the folding kinetics of the
CH11 peptide are multi-fold: (a) the robustness of the peptide sequence renders multiple
mutations feasible, a necessity for elucidating the folding mechanism; (b) the small size of the
peptide also makes it feasible to achieve a mechanistic description of the folding process; (c)
it allows one to examine the kinetic role of those non-native ligands, thus providing a
rationalization of their possible functional role; and (d) because of its small size, this
J Mol Biol. Author manuscript; available in PMC 2010 May 29.
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miniprotein is amenable and should provide a rich model system for further computer
simulation studies.
To study the zinc-induced folding process of the CH11 peptide, it is useful to introduce a probe
that is sensitive to local structure and to mutate potential nonnative ligands, H9 and H22, while
retaining the parent structure. For the CH11 variants studied herein, a single tryptophan (Trp)
residue was introduced to serve as a fluorescent probe of structure, since both cysteine (Cys)
and histidine (His) side chains are efficient quenchers of Trp fluorescence.42 Though the
peptide is tolerant of multiple alanine mutations, mutations involving larger residues may not
be compatible with folding to the native structure. Computational design methods facilitate the
identification of viable mutations. Four structurally-consistent mutants (L7W, T21W, L7W/
H9V, and L7W/H9V/H22I) were designed using a statistical, computationally-assisted design
strategy (SCADS).43,44 The folding process was initiated by mixing a Zn2+ solution with a
CH11 peptide solution using a stopped-flow technique, and the folding kinetics were monitored
by following changes in Trp fluorescence intensity. The Zn2+-induced folding kinetics of the
CH11 peptide are complex and involve at least three kinetic phases. Based on extensive
concentration and temperature dependent studies, a model that is capable of describing the
observed stopped-flow kinetics of these mutants is proposed. This model suggests that the
binding of Zn2+ to the unfolded CH11 peptide involves parallel pathways and that the initially
formed Zn2+-bound peptide can proceed either directly to the native state or to an off-pathway
misligated state.

Results
Identification of Trp-tag sites
Native fluorescence, especially that arising from Trp, is often used in protein folding and
binding studies. However, the native sequence of the CH11 peptide does not contain a suitable
fluorophore for monitoring folding or cofactor binding. Therefore, we have employed a
statistical computational design method (i.e., SCADS) to identify Trp-containing mutants
consistent with the known structure of CH11.40 While the calculations suggest that several sites
may be tolerant toward Trp-mutation, two single mutants, L7W and T21W, were targeted
because in both cases the Trp residue is in proximity to two zinc ligands: C5/C10 for L7W and
H19/C23 for T21W. The probabilities of these two Trp residues at their respective positions
are shown in Figure 2. As shown in the predicted model structures (Figure 2), Trp7 in L7W is
located close to the metal binding pocket, thus, it is expected to be sensitive to Zn2+-ligand
coordination. On the other hand, while the side chain of Trp21 in T21W is highly exposed to
solvent (Figure 2), it is near the zinc-binding site and the location (i.e., sandwiched between
H19 and C23) makes it a good candidate for the observation of local environmental changes
associated with the transition from a heterogeneous ensemble of conformations in the unfolded
state to a well organized structure upon folding.
Identification of mutations for His9 and His22
To elucidate the roles of the two non-binding His residues (i.e., H9 and H22) in CH11 folding,
the site-specific amino acid probability profiles for sites 9 and 22 were calculated. At each
position, 19 amino acids were permitted (i.e., Cys was excluded), and the modeled structure
of the mutant L7W was used. As shown (Figure 2), glutamic acid (Glu) shows slightly higher
probability for site 9 than several other amino acids at Teff = 2 kcal/mol. However, at lower
energies (Teff = 0.5 kcal/mol), the aliphatic nonpolar amino acid valine (Val) is the most
probable amino acid for this site due to the stabilizing short ranged van der Waals interactions.
With the goal of testing the function of metal-reactive His at position 9, it would be desirable
to replace His with an amino acid that is neutral and unlikely to coordinate the metal ion. Thus,
Val was identified to replace His9, resulting in the double mutant L7W/H9V.

J Mol Biol. Author manuscript; available in PMC 2010 May 29.

Tang et al.

Page 4

Further calculations were performed to replace the His22 based on L7W/H9V. As shown
(Figure 2), isoleucine (Ile) and Val are highly probable amino acids, in addition to His, and
have similar average conformational energies as compared to that of His. However, taking into
consideration that Ile has a higher helical propensity than Val for an α-helical motif,45 Ile was
selected to substitute His22, resulting in the triple mutant L7W/H9V/H22I.
CD studies
The CD spectra of the CH11 mutants in aqueous solution, as that shown in Figure S1
(Supporting Information) for apo L7W, show characteristics of unfolded peptides. Addition of
ZnCl2 to the peptide solution, however, leads to a distinct change in the CD spectrum: the
development of the bands around 208 and 222 nm, respectively, consistent with the formation
of a partial helical structure (Supporting Information, Figure S1). These results are in agreement
with the study of Sharpe et al.40 who have shown that upon association with Zn2+, the CH11
peptide folds into a structure that contains a short 310-helix and a short α-helical stretch.
Addition of 5 mM EDTA into the peptide-zinc solution results in a loss of the helical CD signal
(data not shown) due to the chelation of Zn2+ by EDTA,46 further demonstrating the important
structural role of Zn2+ in the folding of these CH11 mutants. In addition, one-dimensional (1D)
proton NMR measurements also indicate that the zinc-bound peptide adopts a folded
conformation (see Figure S2 in Supporting Information for an example).
Moreover, the CD spectra of the CH11 mutants considered here indicate that the helical content
of each peptide is somewhat different. This is likely due to a combination of effects arising
from the difference in helix-forming propensities of different amino acids45 and/or structural
constrains induced by the presence or absence of H9 and/or H22.47 Indeed, Sharpeet al. 40
have shown that the mean residual helicity of the CH11 peptide increases when 15 native
residues are replaced with Ala.
Fluorescence titrations
The Trp fluorescence intensity of these CH11 mutants increases upon association with Zn2+
and is therefore used to determine their apparent Zn2+-binding constants. As an example, the
fluorescence spectra of L7W obtained at various Zn2+ concentrations are shown (Figure 3a).
Interestingly, the fluorescence spectra of all mutants exhibit a common maximum centered at
354 ± 1 nm that is independent of the concentration of Zn2+, indicating that the Trp side chain
is largely exposed to solvent in both the folded and unfolded states. Thus, the increase in Trp
fluorescence upon Zn2+ binding must arise from an alleviation of intramolecular quenching of
the Trp fluorescence by various amino acids,42,48–50 most likely Cys and His residues in the
current case. The study of Chen et al.42 has shown that Cys and protonated His are among the
strongest quenchers of Trp fluorescence existing in natural proteins. As described above, the
single Trp in all of these CH11 mutants is deliberately introduced through design at a position
that is in close proximity to, at least, a pair of putative zinc coordinating residues: C5/C10 or
H19/C23. Therefore, it is expected that the Trp fluorescence of these peptides increases upon
association with Zn2+ because coordination with a metal ion greatly reduces the quenching
efficiency of these residues.48
As indicated (Figure 3b), the total Trp fluorescence intensity (i.e., the integrated area of the
fluorescence spectrum) of these CH11 mutants as a function of Zn2+ concentration can be
described by a 1:1 binding model. The apparent dissociation constants (Kd) determined from
the best fit of these data to this model (i.e., eqs. 1 and 4) are Kd (L7W) = 3.8 ± 0.5 μM, Kd
(T21W) = 0.52 ± 0.35 μM, and Kd (L7W/H9V) = 4.6 ± 0.8 μM. Because the triple mutant
L7W/H9V/H22I was found to form aggregates at relatively high Zn2+ concentrations, we did
not attempt to determine its Kd.
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Stopped-flow kinetics
The Zn2+-induced folding kinetics of these CH11 mutants were investigated by a stopped-flow
fluorescence technique.51 Consistent with the equilibrium measurements, rapid mixing of a
Zn2+ solution with a peptide solution at pH 6.5 leads to the Trp fluorescence to increase as a
function of time. However, the stopped-flow kinetics thus obtained for these mutants are quite
complex. As shown (Figure 4a), the stopped-flow traces of L7W, T21W, and L7W/H9V are
adequately described by a tri-exponential function with well-separated rate constants (Table
1). While such phenomenological kinetic analyses do not provide molecular insights into the
Zn2+-induced folding mechanism of the CH11 peptide, they do show that the CH11 folding is
not a simple two-state cooperative process. This is in marked contrast to results obtained for
other Zn2+-binding peptides,35, 52 which only show pseudo-first-order stopped-flow kinetics
even under different experimental conditions (e.g., different zinc concentrations and pH
values). In addition, concentration dependent measurements show that the rate constant of the
initial or fastest kinetic phase (i.e., k1obs in Table 1) is linearly proportional to the Zn2+
concentration (Figure 4b), typical of a bimolecular reaction taking place under pseudo-firstorder reaction conditions. Therefore, we attribute this kinetic phase to the initial binding of
Zn2+ to the peptide. Moreover, the second-order Zn2+-binding rate constant for L7W and T21W
is determined to be about 1.8 × 106 M−1 s−1, which is comparable to that observed for other
zinc-binding proteins.52–55 To further verify this assignment, additional stopped-flow mixing
experiments were carried out at different pH conditions. As expected (Figure 5), taking T21W
as an example, the rate of the first stopped-flow kinetic phase increases approximately 4 times
when the pH of the final mixed solution is increased from 6.5 to 7.5, due to an increase of the
population of deprotonated ligands (especially deprotonated His). Interestingly, the Zn2+induced folding kinetics of L7W/H9V/H22I can be well described by a bi-exponential function
(Figure 6), suggesting that replacement of H9 and H22 with non-ligating amino acids simplifies
the folding process.
Finally, temperature dependent measurements were carried out in the temperature range of 5
to 30 °C to further characterize the apparent activation energy (Ea) encountered by each kinetic
phase. As shown (Figure 7 and Table 2), all the rate constants show Arrhenius temperature
dependence with an Ea ranging from 6 – 14 kcal/mol.

Discussion
The CH11 peptide is a novel zinc-binding motif found in the first Cys/His-rich region of CREB
binding protein.40 It is known that this peptide binds to zinc through a consensus CCHC motif
(i.e., Cys-X4-Cys-X8-His-X3-Cys wherein Cys and His residues are the ligands for Zn2+) and
forms a thermostable, well-defined tertiary structure that is extremely tolerant to sequence
mutations at non-ligating positions.40,41 In other words, Zn2+-binding provides a major driving
force for CH11 folding. Therefore, this peptide provides an ideal model system for
understanding the mechanism of metal-induced protein folding processes.
Since the native sequence of CH11 peptide does not contain a suitable fluorophore (e.g., Trp)
that can be used to follow the kinetic process of binding or folding using fluorescence-based
techniques, we have employed a statistical computational design method43,44 to identify
structurally consistent, Trp-containing mutants of CH11. First, two single mutants, L7W and
T21W, were identified as the best targets because in both cases the Trp residue is sandwiched
between two zinc ligands, i.e., C5/C10 for L7W and H19/C23 for T21W. Thus, their
fluorescence is likely sensitive to Zn2+-binding. Second, a double mutant, L7W/H9V, and a
triple mutant, L7W/H9V/H22I, were designed to investigate the role of the non-ligating His
residues (i.e., His9 and His22) in the kinetics of CH11 folding. Indeed, both equilibrium and
stopped-flow fluorescence measurements show that upon coordination with Zn2+ the Trp
fluorescence of these mutants increases significantly, indicative of the sensitivity of this
J Mol Biol. Author manuscript; available in PMC 2010 May 29.
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fluorescent probe to metal-induced folding processes. Furthermore, the structural integrity of
these mutants was verified by low-resolution methods (i.e., CD and 1D NMR).
A simple sequential model is inadequate to describe the folding mechanism of the CH11
peptide
Compared to other metal-binding motifs,34,35,54–56 these CH1 mutants exhibit rather complex
1

and slow cofactor-induced folding kinetics. As shown (Figure 4a), the stopped-flow kinetics
of L7W consist of (at least) three exponential phases, indicative of a non-two-state folding
scenario. While this result is not surprising, it is nevertheless interesting as many proteins of
similar size that lack cofactors have been shown to fold in a two-state manner37, 57–59 and on
a much faster time scale.37, 60–62 Therefore, the slower and more complex folding kinetics of
L7W must arise from the fact that the folding of CH11 necessitates Zn2+ ligation in a tetrahedral
geometry.
The fastest phase in the stopped-flow kinetics of L7W is characteristic of a bimolecular
reaction, as its rate constant (i.e., k1obs in Table 1) depends linearly on the Zn2+ concentration
(Figure 4b). Therefore, we attribute this kinetic phase to the initial association of the peptide
with zinc wherein a Zn2+-peptide complex (I1) is formed. Given the fact that the four native
ligands in CH11 are segregated into two pairs, one (C5 and C10) close to the N-terminus and
the other (C23 and H19) close to the C-terminus, it is likely that only two ligands in I1 are
ligated. Indeed, Bombarda et al.35 have recently shown that the first step in the Zn2+-induced
folding kinetics of the distal CCHC finger motif of the HIV-1 nucleocapsid protein corresponds
to the formation of a bidentate state wherein only C36 and H44 are coordinated with the
cofactor. Therefore, the simplest interpretation of the tri-exponential stopped-flow
fluorescence kinetics of L7W is that this initially formed Zn2+-peptide complex, I1, further
evolves to produce the final folded state (F) via a sequential mechanism involving an onpathway folding intermediate (I2), as indicated in Scheme 1. In fact, zinc coordination has been
proposed to proceed in an intrinsically multistep and sequential manner for several peptides.
35, 54, 63 While Scheme 1 can indeed fit the stopped-flow kinetics of L7W obtained at different
Zn2+ concentrations, the microscopic rate constants recovered from the best fit (Supporting
Information, Table S1) however give rise to an equilibrium constant that is not overwhelmingly
favorable for the folded state. Instead, this model indicates that the folding intermediate states
are significantly populated at equilibrium (e.g., [U]:[I1]:[I2]: [F] = 1:9:9:14 at 300 μM Zn2+),
which is inconsistent with previous40 and current equilibrium results (Figure 3b). This
inconsistency suggests that a simple sequential model, such as Scheme 1, is inadequate to
describe the Zn2+-induced folding mechanism of the CH11 peptide.
CH11 folding involves parallel pathways
The inadequacy of Scheme 1 in describing the folding mechanism of the CH11 peptide
promoted us to design and study a second mutant (i.e., T21W) wherein the Trp is placed near
the second group of Zn2+ ligands, H19 and C23. The rationale is to explore whether or not the
Zn2+-induced CH11 folding involves parallel pathways. In principle, the initial binding of
Zn2+ to the peptide could occur at both the N- and C-terminal regions, leading to the formation
of N-Zn2+ and C-Zn2+ (Figure 8). Since Trp fluorescence quenching by various amino acids
is strongly distance dependent, we expect that both L7W and T21W will exhibit similar
fluorescence intensity changes upon the initial binding of Zn2+ if both N-Zn2+ and C-Zn2+ are
formed. Indeed, the relative amplitude of the first stopped-flow kinetic phase of T21W (Table
1), arising from the initial Zn2+-peptide association, is 49%, similar to that (i.e., 56%) of L7W.
Taken together, these results thus suggest that the Zn2+-induced CH11 folding involves at least
two parallel pathways, as shown in Scheme 2, which represents the simplest parallel folding
mechanism wherein N-Zn2+ (I1) and C-Zn2+ (I2) are directly converted to the folded state.
Similar to Scheme 1, this folding mechanism possesses sufficient number of (fitting)
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parameters that can be adjusted to fit the observed stopped-flow kinetics of both L7W and
T21W. However, the microscopic rate constants recovered from the best fits (Supporting
Information, Table S2) suggest that this folding scheme is also unlikely to be correct. For
example, the values of both k3 and k−3 for T21W nearly approach zero, suggesting that T21W
can only fold to its native state via I2, whereas in the case of L7W k3 is comparable to k4. While
it is possible that the folding mechanism of T21W is different from that of L7W, it seems more
plausible that a more complicated kinetic scheme is required.
CH11 folding involves a misligated intermediate
Since the CH11 peptide contains two ‘extra’ zinc ligands (i.e., H9 and H22), it is therefore
possible that its complex folding kinetics upon association with zinc arise from the formation
of a misligated state involving either H9 or H22 or both. To test this possibility, we have further
studied a double mutant, L7W/H9V, and a triple mutant, L7W/H9V/H22I. If misligation
involving both H9 and H22 indeed occurs during CH11 folding, we would expect that only the
stopped-flow kinetics of the triple mutant, wherein all non-native zinc ligands are replaced by
non-ligating amino acids, become simpler. Indeed, the Zn2+-induced folding kinetics of L7W/
H9V remain tri-exponential (Figure 4a), whereas those of L7W/H9V/H22I can be well
described by a bi-exponential function (Figure 6). Taken together, these results hence support
the idea that the Zn2+-induced CH11 folding process involves misligation of Zn2+ to H9 and/
or H22.
While other mechanisms are possible, Scheme 3 represents the simplest scenario wherein such
a misligated state (i.e., I3) is populated. As shown (Supporting Information, Figure S3), Scheme
3 not only adequately fits the stopped-flow kinetics of L7W and T21W obtained under different
conditions, but also yields physically meaningful fitting parameters (Table 3). For example,
the values of k1 and k2 are comparable for both mutants, consistent with the aforementioned
picture that the initial binding of Zn2+ to the peptide proceeds in two parallel pathways wherein
N-Zn2+ and C-Zn2+ are formed. In addition, the overall bimolecular rate constant for zinc
binding is determined to be ~1.5 × 106 M−1 s−1 (i.e., the sum of k1 and k2 in Table 3), which
is similar to that determined according to the Eigen-Wilkins mechanism (i.e., 5 × 106 M−1
s−1 for Zn2+ ligation).54 Furthermore, both k5 and k6 are larger than k−5 and k−6, indicating that
I3 is only transiently populated (same as I1 and I2). More importantly, the overall equilibrium
constant for each peptide (i.e., Kd (L7W) = 20.8 μM, Kd (T21W) = 3.2 μM, and Kd (L7W/H9V)
= 30.3 μM) calculated based on the recovered microscopic rate constants is comparable to that
determined from the equilibrium titration experiment (Figure 3b), which assumes a simpler
binding model.
The relative fluorescence intensity determined from the fitting for every species provides a
more stringent test of the current model. Since the major Trp fluorescence quenchers in both
L7W and T21W are Cys and His residues, it is possible to rationalize, albeit in a qualitative
manner, the relative fluorescence intensities of the folded, unfolded and intermediate states
involved in a specific folding mechanism. For Scheme 3, it is expected that the fluorescence
intensity of F is higher than those of U, I1 and I2 because more Trp fluorescence quenchers
are bound to Zn2+ in the folded state (F). Similarly, if I1 and I2 represent N-Zn2+ and CZn2+ in Scheme 3, respectively, one would expect that for L7W (T21W) the fluorescence
intensity of I1 (I2) is larger than that of I2 (I1) because in this case the Trp fluorophore is located
near the N-terminal (C-terminal) ligands. As indicated (Table 3), the relative fluorescence
intensities of F, I1 and I2 recovered from the best fits of the stopped-flow data of L7W and
T21W to Scheme 3 indeed meet these expectations. Moreover, for both mutants the offpathway intermediate I3 exhibits the largest relative fluorescence intensity, suggesting that it
adopts a conformation wherein the Trp fluorescence quenching by all potential quenchers (i.e.,
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all Cys and His residues) is maximally reduced. Thus, this result corroborates the idea that the
misligated state involves H9 and/or H22.
While the structure of the misligated state cannot be exclusively determined from the current
study, a possible Zn2+ coordination is presented in Figure 9, where Zn2+ not only coordinates
with the native ligands, but is also associated with one or both of the non-native ligands (i.e.,
H9 and H22). Another possibility is that both H9 and H22 are in rapid exchange with one of
the native ligands.55, 64 In addition, the more pronounced increase in the relative fluorescence
intensity of I3 (compared to F) for L7W (and L7W/H9V) than that for T21W (Table 3) likely
arises from difference in the orientations of the indole rings of Trp7 and Trp21. As shown in
the model structures provided by the design calculations (Figure 2), the side chain of Trp7 is
oriented towards the zinc and is thus expected to be more sensitive than Trp21 to changes in
the coordination number of Zn2+.
Moreover, fitting the stopped-flow kinetics of L7W/H9V to Scheme 3 and those of L7W/H9V/
H22I to Scheme 2 (where I3 is no longer needed because H9 and H22 are deleted) also yields
a set of microscopic rate constants and relative fluorescence intensities (Table 3) that meet the
aforementioned structural characteristics of I1, I2, and I3. For example, k1 of L7W/H9V is
smaller than that of L7W as a result of H9 deletion, and both k1 and k2 of L7W/H9V/H22I are
decreased as compared to those of L7W as a result of H9 and H22 deletion. In addition, the
resultant microscopic rate constants for L7W/H9V/H22I (i.e., k3, k−3, k4, and k−4) indicate that
deleting non-native ligands results in a less stable CH11 fold. This is consistent with the fact
that both H9 and H22 are conserved in the CH11 sequence40 to some extent and also similar
to that observed in a recent study47 on the NZF-1 zinc-binding domain, which showed that an
‘extra’ histidine is not only important for maintaining the tertiary structure of the peptide, but
it can also coordinate with the Zn2+ when the native histidine is absent.
Taken together, our results show that Scheme 3 is capable of providing a comprehensive
description of the zinc-induced folding kinetics of four computationally designed mutants of
the CH11 peptide as monitored by Trp fluorescence. While earlier studies have shown that
binding of Zn2+ to a peptide could proceed in a multistep and sequential manner35,54,65 and
that misligation of nearby non-native ligands to Zn2+ could occur in the later stage of the folding
process,65 the current model highlights the importance of parallel, binding-coupled folding
pathways, as well as the non-native ligands, for achieving a higher metal binding affinity.
Furthermore, the finding that the two non-native ligands (i.e., H9 and H22) stabilize the
CH11 fold even though they complicate the folding kinetics provides strong evidence
suggesting that in certain cases functional requirements for folding could produce significant
local frustrations in the folding energy landscape, thus slowing down folding. Similar
conclusions regarding the divergent requirements for folding and function have also been
reached in other studies.66–69
Estimating the loop closure rate
Temperature-dependent measurements indicate that all three stopped-flow kinetic phases
exhibit Arrhenius temperature dependence with an apparent activation energy ranging from 6
– 14 kcal/mol (Table 2), depending on the kinetic phase and mutant. While it is difficult to
rationalize these apparent activation energies and also the subtle differences among them, they
likely arise from one of the following events:70 (a) dehydration of Zn(H2O)62+, (b)
deprotonation of His and Cys ligands, (c) peptide chain motions required to bring the
corresponding ligands to a suitable position for coordination, and (e) disruption of misligation
for correct folding. Regardless of the origin of those energetic barriers, however, the value of
obtained for each CH11 mutant could be used to estimate the loop closure rate for short
peptides. According to Scheme 3, in order to form the final folded and closed conformation of
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CH11 from either N-Zn2+ (I1) or C-Zn2+ (I2) the opposite end of the peptide chain must be
brought to a suitable distance to the peptide-bound Zn2+, so that further coordination can take
place. Therefore, using the apparent rate constant and the activation energy obtained for the
third kinetic step, which approximately measures the total rate leading to the formation of the
native and closed conformation of CH11 from both N-Zn2+ and C-Zn2+, we can estimate the
free diffusion rate of the CH11 peptide chain in aqueous solution. In other words, the prefactor
provides an upper limit for the rate of the
in the Arrhenius equation
peptide chain diffusion. At 15 °C, this rate was estimated to be 2.1 × 107 s−1 for L7W, 6.6 ×
106 s−1 for L7W/H9V, and 7.0 × 109 s−1 for T21W. Despite its simplicity, this simple analysis
yields peptide chain diffusion rates that are in good agreement with those determined by
measuring the end-to-end collision rate in short peptides (e.g., 7.1 × 106 to 1.5 × 108 s−1),71,
72 which provides further support for the proposed zinc-induced folding mechanism of
CH11.

Conclusions
In summary, the Zn2+-induced CH11 folding can be described by a parallel pathway wherein
Zn2+ first binds to either the N-terminal group of ligands (C5/C10/H9) or C-terminal group of
ligands (H19/H22/C23). This initial binding event is followed by a rearrangement of the peptide
chain, leading to the closure of peptide loop and the concomitant formation of the native zinc
tetrahedral coordination. During folding, however, a misligated Zn2+-peptide complex is also
transiently populated which may have a higher coordination number. While the existence of
non-native Zn2+ ligands is responsible for the formation of this off-pathway folding
intermediate, these ‘extra’ ligands nevertheless facilitate the binding of Zn2+ to CH11 peptide
and also enhance the stability of the final fold. In addition, the loop closure rate of this peptide
is estimated to be in the range of 6.6 × 106 to 7.0 × 109 s−1.

MATERIALS AND METHODS
Materials and sample preparation
All peptides were synthesized using standard Fmoc-based solid-phase method on a PS3 peptide
synthesizer (Protein Technologies, MA) and purified by reverse-phase high performance liquid
chromatography. The identity of each peptide was further verified by MALDI-TOF mass
spectrometry. All peptide solutions were prepared by directly dissolving lyophilized peptide
solid in 10 mM deoxygenated Tris buffer (pH 6.5 or 7.5, depending on the experiment). To
prevent cysteine from oxidation, each peptide solution also contains a 10-fold excess of tris(2carboxyethyl) phosphine hydrochloride (TCEP·HCl) (Pierce Biotechnology, IL). The final
peptide concentration of each solution was determined optically using Trp absorbance at 280
nm and a molar extinction coefficient of 5600 M−1 cm−1. The Zn2+ solution was freshly
prepared before each experiment by dissolving ZnCl2 (Sigma, MO) in 10 mM deoxygenated
Tris buffer (pH 6.5 or 7.5).
Equilibrium CD measurement
Far-UV CD spectra at 25 °C were collected on an AVIV 62DS spectropolarimeter (Aviv
Associates, NJ) using a 1 mm quartz cell. For each case, the concentrations of the peptide and
Zn2+ were ~30 μM and 1 mM, respectively.
Equilibrium fluorescence measurement
Trp fluorescence spectra were collected under a nitrogen atmosphere on a Fluorolog 3.10
spectrofluorometer (Jobin Yvon Horiba, NJ) using a 1 cm quartz sample holder. The excitation
wavelength was 285 nm and the spectral resolution was 2 nm (for both excitation and emission).
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Equilibrium binding experiment
The Zn2+-binding affinity of the CH11 mutants at 15 °C was determined by Trp fluorescence
titration. The Zn2+-peptide solution (10 μM peptide) for each measurement was prepared by
adding an appropriate aliquot of a 4 mM ZnCl2 stock solution to a peptide solution, which was
allowed to equilibrate for 5 minutes before fluorescence measurement. The total fluorescence
of each Zn2+-peptide solution was taken as the sum of those of the free and Zn2+-bound
peptides, i.e.,
(1)

where Fint is the integrated area of the fluorescence spectrum, Ff and Fb represent the molar
fluorescence intensities of the free and Zn2+-bound peptides, respectively, and [P]f and [P]b
denote the molar concentrations of the free and Zn2+-bound peptides, respectively. For 1:1
binding, [P]f and [P]b follow the following relationship,

(2)

where Kd is the dissociation constant of the Zn2+-peptide complex. Since Zn2+ also binds to
Tris, the Zn2+ concentration ([Zn2+]) in the above equation should also satisfies the following
relationship,

(3)

where Kd′ is the dissociation constant of the Zn2+-Tris complex (Kd′= 11.5 mM),73 and
[Tris]f and [Tris]b are the molar concentrations of the free and Zn2+-bound Tris molecules.
Since Kd′ is relatively large and the total concentration of Tris (i.e., [Tris]T = [Tris]f + [Tris]b
= 10 mM) is much larger than that of [Zn2+] (in μM range), we have assumed that [Tris]f =
[Tris]T in the derivation of the following equation,

(4)

where [P]T is the total concentration of the peptide. For each experiment, the total
concentrations of the peptide, Zn2+, and Tris were known. Thus, eqs. (1) and (4) allow one to
determine the dissociation constant of the Zn2+-peptide complex via fitting the equilibrium
fluorescence binding curve (i.e., Figure 3b) by varying Kd, Fb and Ff.
Stopped-flow measurement
The zinc-induced CH11 folding kinetics were monitored via Trp fluorescence using a SFM-300
stopped-flow module (Bio-logic, Claix, France) equipped with homebuilt optics, the detail of
which has been described elsewhere.51 In the current study, a microcuvette (μFC-08) with an
optical pathlength of 0.8 mm was used and the dead time of the system was ~600 μs determined
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by the method of N-acetyl-tryptophanamide fluorescence quenching by N-bromo-succinimide.
The stopped-flow kinetics were initiated by mixing equal volumes of a peptide solution and a
ZnCl2 solution. The final peptide concentration was 10 μM and the final Zn2+ concentration
was 0.1–0.3 mM, depending on the experiment. The Trp fluorophore was excited at 285 nm
and the resultant fluorescence (for λem > 315 nm) was measured by a photomultiplier tube.
Sample temperature (5–30 °C) was controlled by a Thermo Neslab RTE-7 circulator (Thermo,
NH). The stopped-flow traces shown in the Figures correspond to an average of 6–10 shots.
The stopped-flow kinetics thus obtained were fit to either a multi-exponential function using
a nonlinear least squares method or a kinetic model, i.e., Scheme 1, 2 or 3. For the latter case,
all individual kinetic steps were assumed to be first-order with respect to each species and the
corresponding rate equations were solved numerically using the program Scientist (Micromath
Research, LC) to yield the best fit.
Mutant design
Four structurally consistent mutants of CH11 were identified using a statistical,
computationally assisted design strategy (SCADS), the details of which have been described
elsewhere.30,43,44,74 Briefly, the site-specific probabilities of the amino acids at variable
positions in a given structure are calculated, allowing identification of structurally consistent
mutations. These probabilities are estimated by optimizing an effective sequence-conformation
entropy subject to constraints involving the total average energy of the structure, as measured
using an atom-based energy function. The conformational energy is represented as an average
over sequence and side chain conformational (rotamer) states of the amino acids,30,43,44 where
all interatomic interactions are quantified using the AMBER force field75 with a modified
hydrogen bonding energy76 and a distance dependent electrostatic dielectric constant (ε =
4rij, where rij is the distance between atoms i and j). The nonbonding parameters for Zn2+ were
obtained from Hoops et al. (Lennard-Jones parameters: R* = 1.1 Å, ε = 0.012 kcal/mol; partial
charge: qZn2+=0.866).77 The protein backbone coordinates were constrained to those in the
experimentally determined NMR structure (PDB code: 1liq).40 Side chain variability was
addressed using a backbone-dependent rotamer library with maximum 81 rotamers per amino
acid.78
The sequence design was divided into two components. The first involved identifying sites for
introducing a Trp as an intrinsic fluorescent probe. The residue positions in the protein were
scanned for possible mutations, allowing Trp, Tyr and wild type amino acid, while fixing the
remaining residues at their wild type amino acids. For all calculations, the four metal-binding
residues (Cys5, Cys10, His19 and Cys23) were fixed to their wild type conformations, while
other residues were allowed to take on rotamer states contained in the library. The second part
of the design identified suitable mutations for the two non-ligating histidines (His9 and His22),
to inform the roles of these non-ligating histidines in folding. All 19 natural amino acids except
Cys were allowed for the site-directed mutagenesis of these two sites. The amino acid
probabilities were obtained at medium (Teff = 2.0 kcal/mol) and low (Teff = 0.5 kcal/mol)
effective temperatures. Teff represents an effective temperature conjugate to the configurational
energy of the sequences; lower temperatures correspond to lower average energy of the
sequence when in the target structure.30,44 In addition, mutations between the two sites 9 and
22 were not correlated with each other, presumably due to the relatively large distance between
them (dCβ−Cβ = 14.1 Å).
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Figure 1.

The NMR structures of CH11 Zn-binding domain (PDB code: 1liq).40 Zn coordinating residues
(gray) and residues of triple mutant L7W/H9V/H22I (magenta) are shown.

J Mol Biol. Author manuscript; available in PMC 2010 May 29.

Tang et al.

Page 17

Figure 2.

Site-specific amino acid probability profiles for introduction of Trp-mutation on L7 and T21
(left) and His-replacement for H9 and H22 (right). Teff = 0.5 kcal/mol. For H9, probabilities
at two different sampling temperatures of 2.0 and 0.5 kcal/mol are presented with gray squares
and red solid bars, respectively. Mutated residue appears in yellow. Zn-coordinating residues
(gray) and residues of triple mutant L7W/H9V/H22I (magenta) are shown.
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Figure 3.

(a) Representative Trp fluorescence spectra of L7W at various Zn2+ concentrations, as
indicated. The peptide concentration was 10 μM (in 10 mM Tris buffer, pH 6.5). (b) Integrated
area of the Trp fluorescence of CH11 mutants versus Zn2+ concentration. Lines are fits of these
data to the binding model described in the text.
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Figure 4.

(a) Representative stopped-flow kinetics of L7W, T21W, and L7W/H9V (these data have been
offset for easy comparison) at 15 °C and pH 6.5, which were initiated by mixing equal volumes
of a peptide solution and a ZnCl2 solution. The final peptide and Zn2+ concentrations were 10
μM and 0.15 mM, respectively. Smooth lines represent the best fits to the following triexponential function, F(t) = B − C × [A1%·exp(−k1obst) + A2%·exp(−k2obst) + A3%·exp
(−k3obst)], and the resultant best-fit parameters are listed in Table 1. (b) The observed rate
constant of the first or fastest kinetic phase (i.e., k1obs) versus Zn2+ concentration. Linear
regressions to these data yield those straight lines with the following slopes: 1.8×106 M−1
s−1 (L7W), 1.8×106 M−1 s−1 (T21W), and 1.2×106 M−1 s−1 (L7W/H9V).
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Figure 5.

Stopped-flow kinetics of T21W obtained at pH 6.5 and 7.5, as indicated. These data have been
offset for easy comparison.
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Figure 6.

Stopped-flow kinetics obtained by mixing equal volumes of a L7W/H9V/H22I peptide solution
and a ZnCl2 solution at 15 °C. The final peptide and Zn2+ concentrations were 10 μM and 0.15
mM, respectively. The smooth line is the best fit of these data to a bi-exponential function, and
the resultant rate constants are k1obs = 92 s−1 and k2obs = 6.8 s−1.
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Figure 7.

Arrhenius plots of the rate constants obtained by fitting the stopped-flow kinetics of the
CH11 mutants (as indicated) to the tri-exponential function discussed in Figure 4 caption. Lines
, where is the apparent activation
are fits to the Arrhenius equation,
energy for kinetic phase i (i = 1, 2, or 3) and its value is listed in Table 2.

J Mol Biol. Author manuscript; available in PMC 2010 May 29.

Tang et al.

Page 23

Figure 8.

Two putative Zn2+-peptide complexes formed after the initial binding of zinc, where H9 and
H22 are the two non-native ligands which may also participate in binding.
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Figure 9.

A possible zinc coordination in the misligated state.
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Scheme 1.

A sequential folding mechanism involving an on-pathway folding intermediate.
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Scheme 2.

A parallel folding mechanism involving two on-pathway folding intermediates.
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Scheme 3.

A parallel folding mechanism involving two on-pathway folding intermediates and also a
misligated state (I3).
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k1obs k2obs k3obs A1% A2% A3%
L7W (pH 6.5) 282 ± 29 11 ± 1 2.0 ± 0.1 56 ± 5 10 ± 2 34 ± 2
T21W (pH 6.5) 217 ± 10 25 ± 7 1.4 ± 0.1 49 ± 6 31 ± 4 20 ± 2
L7W/H9V (pH 6.5) 174 ± 10 8 ± 1 2.2 ± 0.6 31 ± 1 11 ± 2 58 ± 3
T21W (pH 7.5) 956 ± 50 39 ± 3 1.3 ± 0.2 54 ± 6 30 ± 4 16 ± 2

Phenomenological rate constant (kiobs) and relative amplitude (Ai%) of each kinetics phase obtained by fitting the stopped-flow kinetics presented in Figure
4a and Figure 5 to a tri-exponential function.

Table 1

Tang et al.
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Table 2

Apparent activation energy of each stopped-flow kinetic phase.
Ea1 (kcal/mol)
Ea2 (kcal/mol)
Ea3 (kcal/mol)

L7W T21W L7W/H9V
6.2±0.5 7.1±1.7 8.4±1.5
14.1±1.2 10.2±0.5 12.8±0.3
9.3±0.6 12.9±0.3 12.0±1.5
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Table 3

Microscopic rate constants (ki) and relative fluorescence intensities (Q) obtained from globally fitting the stoppedflow kinetics obtained at different Zn2+ concentrations for each mutant to Scheme-3 or Scheme-2 (for L7W/
H9V/H22I only).
L7W
T21W
L7W/H9V L7W/H9V/H22I
k1 (M−1 s−1) (5.8 ± 0.5) × 105 (6.2 ± 1.2) × 105 (2.0 ± 0.4)× 105 (2.4 ± 0.6) ×105
k−1 (s−1)
76 ± 10
49 ± 21
77 ± 4
5±3
k2 (M−1 s−1) (8.6 ± 0.4) × 105 (8.5 ± 1.6) × 105 (6.9 ± 0.7) × 105 (3.5 ± 0.2) ×105
k−2 (s−1)
56 ± 2
12 ± 1
156 ± 10
0.2 ± 0.1
k3 (s−1)
2.6 ± 0.8
3.0 ± 0.9
7.9 ± 3
3.9 ± 0.5
k−3 (s−1)
0.1 ± 0.1
(3 ± 1) × 10−4
0.6 ± 0.2
1.8 ± 0.4
k4 (s−1)
1.4 ± 0.1
1.3 ± 0.4
0.1 ± 0.1
2.1 ± 0.9
k−4 (s−1)
0.7 ± 0.3
0.3 ± 0.1
0.02 ± 0.01
1.2 ± 0.5
k5 (s−1)
22 ± 8
9±2
7 ± 0.3
-k−5 (s−1)
0.2 ± 0.1
7±3
0.5 ± 0.3
-k6 (s−1)
4±2
7±2
~0
-k−6 (s−1)
0.4 ± 0.2
5±1
0.5 ± 0.05
-Q(U)
8.2 ± 0.6
11.6 ± 0.5
12 ± 3
9.9 ± 0.5
Q(I1)
15 ± 3
13 ± 1
19 ± 3
12.0 ± 0.2
Q(I2)
11 ± 2
14.9 ± 0.5
14 ± 2
11.6 ± 0.2
Q(I3)
80 ± 20
18 ± 4
49 ± 5
-Q(F)
16 ± 1
16 ± 1
20 ± 3
12.1 ± 0.2
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